A Phase II Tolerability Study of Cisplatin Plus Docetaxel as Adjuvant Chemotherapy for Resected Non-small Cell Lung Cancer

INTRODUCTION: We undertook this phase II study to measure postoperative drug delivery and toxicity of cisplatin plus docetaxel in patients with resected stage I-III non-small cell lung cancer. METHODS: The primary endpoint was amount of cisplatin delivered over a planned four cycles of adjuvant chem...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Azzoli, Christopher G., Krug, Lee M., Miller, Vincent A., Rizvi, Naiyer A., Kris, Mark G., Dunne, Megan, Farmer, Amy, Pizzo, Barbara, Tyson, Leslie, Seeger, Teresa, Coleman, Barbara, Moore, Erin, Lastinger, Lauren, Venkatraman, Ennapadam, Rudin, Charles M.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: 2007
Onderwerpen:
Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3715043/
https://ncbi.nlm.nih.gov/pubmed/17607120
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/JTO.0b013e318074bbd0
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items